跳至主要内容
临床试验/CTRI/2024/09/074408
CTRI/2024/09/074408招募中不适用

Assessing Prevalence, Patient Satisfaction and Genetic Risk Factors of Psoriasis and Vitiligo

Sri Ramachandra Institute of Higher Education and Research DU1 个研究点 分布在 1 个国家目标入组 435 人开始时间: 2024年9月30日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
435
试验地点
1
主要终点
The prevalence of psoriasis and vitiligo, patient satisfaction with their current treatment regimen

研究概览

简要总结

Vitiligo, Psoriasis an autoimmune disease triggered by genetic susceptibility and environmental factors. Phototherapy, using UV radiation and bakuchiol from Psoralea corylifolia reduces autoimmune destruction and shows promising anti-inflammatory effects for both conditions as per literature. This study aims to assess the prevalence, patient satisfaction, and genetic risk factors of psoriasis and vitiligo , recruiting 435 patients from SRIHER’s dermatology clinic over one year. Data will be collected through standardized questionnaires and pedigree analysis. The study will include adults with active vitiligo or psoriasis and exclude pregnant women. Data analysis using SPSS software The findings aim to enhance management and treatment strategies for these chronic dermatological disorders.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Male or nonpregnant female patients aged above 18 year
  • Patients with dermatological conditions like vitiligo and psoriasis
  • Active vitiligo, defined as appearance of new areas of depigmentation or progression of existing areas of depigmentation
  • Active psoriasis with shades of purple or gray scale on brown or Black skin and pink or red with silver scale on white skin.

排除标准

  • Pregnancy or breastfeeding women
  • Alcohol or drug abuse
  • Uncooperative patients
  • Skin malignancies (current or a history of skin malignancy within 5 years preceding screening).

结局指标

主要结局

The prevalence of psoriasis and vitiligo, patient satisfaction with their current treatment regimen

时间窗: This study involves assessing the prevalence of psoriasis and vitiligo and patient satisfaction with the treatment with their current treatment regimen using questionnaire so this study do not have any time points.

次要结局

  • 1. The genetic risk factors involved & to understand the incidence of comorbidities due to the disease.(2. The impact of COVID-19 vaccination on the disease.)

研究者

发起方
Sri Ramachandra Institute of Higher Education and Research DU
申办方类型
Other [Funding Society]
责任方
Principal Investigator
主要研究者

Samanvitha P

Sri Ramachandra Institute of Higher Education and Research

研究点 (1)

Loading locations...

相似试验